<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tblu17" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">MAP3K8 inhibitor dose</th><th valign="top">Constant (vehicle)</th><th valign="top">Antibody</th><th valign="top">Effect size <italic>d</italic></th><th valign="top">A priori power</th><th valign="top">Sample size <break/>per group</th></tr></thead><tbody><tr><td colspan="6" valign="top">2% variance</td></tr><tr><td rowspan="2" valign="top">20 &#181;M</td><td rowspan="2" valign="top">0 &#181;M</td><td valign="top">pMEK</td><td valign="top">88.8889</td><td valign="top">99.9%</td><td valign="top">3</td></tr><tr><td valign="top">pERK</td><td valign="top">20.4225</td><td valign="top">99.9%</td><td valign="top">3</td></tr><tr><td colspan="6" valign="top">15% variance</td></tr><tr><td rowspan="2" valign="top">20 &#181;M</td><td rowspan="2" valign="top">0 &#181;M</td><td valign="top">pMEK</td><td valign="top">11.8519</td><td valign="top">99.9%</td><td valign="top">3</td></tr><tr><td valign="top">pERK</td><td valign="top">2.72300</td><td valign="top">80.2%</td><td valign="top">4</td></tr><tr><td colspan="6" valign="top">28% variance</td></tr><tr><td rowspan="2" valign="top">20 &#181;M</td><td rowspan="2" valign="top">0 &#181;M</td><td valign="top">pMEK</td><td valign="top">6.34921</td><td valign="top">95.1%</td><td valign="top">3</td></tr><tr><td valign="top">pERK</td><td valign="top">1.45875</td><td valign="top">86.6%</td><td valign="top">8</td></tr><tr><td colspan="6" valign="top">40% variance</td></tr><tr><td rowspan="2" valign="top">20 &#181;M</td><td rowspan="2" valign="top">0 &#181;M</td><td valign="top">pMEK</td><td valign="top">4.44444</td><td valign="top">99.2%</td><td valign="top">4</td></tr><tr><td valign="top">pERK</td><td valign="top">1.02113</td><td valign="top">81.1%</td><td valign="top">12</td></tr></tbody></table></table-wrap>